Log in to save to my catalogue

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717003

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease

About this item

Full title

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease

Publisher

England: BioMed Central Ltd

Journal title

BMC nephrology, 2013-07, Vol.14 (1), p.145-145, Article 145

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Zinc-alpha2-glycoprotein (AZGP1) is a secreted protein which is synthesized in a variety of cell types. AZGP1 has functionally been implicated in lipid metabolism, the regulation of cell cycling and cancer progression. Previous studies have shown increased circulating AZGP1 levels in patients with chronic kidney disease but AZGP1 has not been inves...

Alternative Titles

Full title

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717003

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717003

Other Identifiers

ISSN

1471-2369

E-ISSN

1471-2369

DOI

10.1186/1471-2369-14-145

How to access this item